Cargando…
酪氨酸激酶抑制剂治疗期间PH(−)细胞出现克隆性染色体异常对慢性髓性白血病患者预后的影响
OBJECTIVE: To investigate the characteristics and prognosis of clonal chromosomal abnormalities appearing in Philadelphia negative metaphases (CCA/Ph(−)) cells in chronic myeloid leukemia (CML) with tyrosine kinase inhibitor (TKI) therapy. METHODS: The clinical data of 30 cases with CCA/Ph(−) during...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342545/ https://www.ncbi.nlm.nih.gov/pubmed/30929388 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.03.009 |
Ejemplares similares
-
慢性髓性白血病酪氨酸激酶抑制剂治疗后出现Ph(−)细胞染色体异常八例临床观察
Publicado: (2016) -
酪氨酸激酶抑制剂治疗慢性髓性白血病继发Ph阴性+8染色体异常骨髓增生异常综合征一例报告并文献复习
Publicado: (2019) -
儿童慢性髓性白血病酪氨酸激酶抑制剂停药的研究进展
Publicado: (2023) -
慢性髓性白血病患者酪氨酸激酶抑制剂自动停药的多中心回顾性研究
Publicado: (2018) -
慢性髓性白血病酪氨酸激酶抑制剂治疗过程中继发Ph染色体阴性急性早幼粒细胞白血病一例
Publicado: (2021)